Quality of life for long-term breast cancer survivors is not affected by ethnicity, according to a recent study that appeared in the journal Cancer.
Quality of life for long-term breast cancer survivors is not affected by ethnicity, according to a recent study that appeared in the January 15th issue of Cancer.
Researchers examined the relationship between ethnicity and quality of life for 278 breast cancer patients, 117 of whom were black and 161 of whom were white. Overall, the study found that long-term breast cancer survivors had a good quality of life and viewed their health to be as good as women who did not have cancer or other life-threatening illnesses.
The study examined physical, psychological, social and functional well-being. Researchers asked participants about their life stress levels and health perceptions. Women who had better health perceptions, fewer stress factors, higher incomes, more education and partners enjoyed a higher quality of life, regardless of race.
"Race seems to play no role in determining the quality of life for long-term breast cancer survivors. However, socio-ecological factors, such as life stress, having a partner and levels of education and income were shown to be more relevant," said study co-author Kimlin Ashing-Giwa. "It's not a matter of race, it's a matter of context." PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.